NCT07540325Not yet recruiting
Effects of Cognitive Dual-Task on Gait in Parkinson's Disease
Investigating the Effects of Cognitive Dual-Task on Gait in Individuals With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
The aim of this study is to evaluate gait in individuals diagnosed with PD under tasks involving different cognitive domains, to compare the results with those of age and sex-matched healthy individuals, and to determine which cognitive function has the greatest impact on gait in PD.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 24 Mar 2026
- Start date
- Apr 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- Gazi University
- Diseases
- Parkinson disease
- NCT number
- NCT07540325
What you commit to
- Study type: Observational
- Planned participants: 30
- From Apr 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of any neurological disorder other than Parkinson's Disease
- Presence of any cardiopulmonary or musculoskeletal condition that may impair safe ambulation
- Presence of any neurological disorder
- Presence of any cardiopulmonary or musculoskeletal condition that may affect safe ambulation
Other
- A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS)
- Presence of visual or auditory impairments that cannot be corrected with assistive devices
- A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS)
- Presence of visual or auditory impairments that cannot be corrected with assistive devices
Who the study is looking for
- A clinical diagnosis of Parkinson's Disease confirmed by a neurologist according to the United Kingdom Parkinson's Disease Society Brain Bank diagnostic criteria
- Classified between stages 1 and 3 according to the Modified Hoehn and Yahr Staging Scale
- Aged between 40 and 80 years
- A score of at least 21 on the Montreal Cognitive Assessment (MoCA)
- Ability to walk continuously for at least 10 minutes without interruption and without the use of any assistive walking device
- Having received at least 5 years of formal education
- Aged between 40 and 80 years
- A score of at least 21 on the Montreal Cognitive Assessment (MoCA)
Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.